Olon Spa, based in Italy, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is LEVOKETOCONAZOLE, with a corresponding US DMF Number 42268.
Remarkably, this DMF maintains an Active status since its submission on July 31, 2025, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 30, 2025, and payment made on July 28, 2025, indicating their dedication to facilitating drug approvals, Categorized as Type II